Endo International PLC (NASDAQ:ENDP) (TSE:ENL) – Analysts at Cantor Fitzgerald boosted their FY2017 EPS estimates for Endo International PLC in a report released on Sunday. Cantor Fitzgerald analyst L. Chen now expects that the company will post earnings of $3.64 per share for the year, up from their previous estimate of $3.35. Cantor Fitzgerald has a “Neutral” rating and a $7.00 price objective on the stock. Cantor Fitzgerald also issued estimates for Endo International PLC’s FY2018 earnings at $3.11 EPS.

Several other equities research analysts have also recently issued reports on the company. Oppenheimer Holdings, Inc. reissued a “hold” rating on shares of Endo International PLC in a research note on Sunday, July 23rd. ValuEngine cut Endo International PLC from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Zacks Investment Research raised Endo International PLC from a “hold” rating to a “buy” rating and set a $9.75 price objective for the company in a research note on Wednesday, October 11th. Royal Bank Of Canada set a $9.00 target price on Endo International PLC and gave the company a “hold” rating in a report on Tuesday, October 17th. Finally, Mizuho reiterated a “buy” rating and issued a $14.00 target price (down from $19.00) on shares of Endo International PLC in a report on Tuesday, September 12th. Four investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and five have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $11.67.

TRADEMARK VIOLATION WARNING: “Equities Analysts Offer Predictions for Endo International PLC’s FY2017 Earnings (ENDP)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/17/equities-analysts-offer-predictions-for-endo-international-plcs-fy2017-earnings-endp.html.

Shares of Endo International PLC (NASDAQ ENDP) opened at $7.24 on Wednesday. The company has a debt-to-equity ratio of 10.78, a quick ratio of 0.86 and a current ratio of 1.08. The stock has a market capitalization of $1,567.66, a price-to-earnings ratio of 1.45, a price-to-earnings-growth ratio of 1.91 and a beta of 0.53. Endo International PLC has a one year low of $5.77 and a one year high of $18.05.

Endo International PLC (NASDAQ:ENDP) (TSE:ENL) last posted its earnings results on Thursday, November 9th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.06. The company had revenue of $786.90 million during the quarter, compared to analysts’ expectations of $794.93 million. Endo International PLC had a positive return on equity of 66.98% and a negative net margin of 126.97%. The firm’s quarterly revenue was down 11.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.01 earnings per share.

A number of hedge funds have recently bought and sold shares of the stock. Teachers Advisors LLC lifted its stake in Endo International PLC by 1.9% in the 2nd quarter. Teachers Advisors LLC now owns 840,470 shares of the company’s stock valued at $9,388,000 after buying an additional 15,928 shares in the last quarter. Diamond Hill Capital Management Inc. lifted its stake in shares of Endo International PLC by 46.8% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 716,670 shares of the company’s stock worth $6,138,000 after purchasing an additional 228,426 shares during the period. TIAA CREF Investment Management LLC lifted its stake in shares of Endo International PLC by 1.6% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 649,535 shares of the company’s stock worth $7,255,000 after purchasing an additional 10,387 shares during the period. Ameriprise Financial Inc. lifted its stake in shares of Endo International PLC by 4.9% during the 2nd quarter. Ameriprise Financial Inc. now owns 581,552 shares of the company’s stock worth $6,497,000 after purchasing an additional 27,414 shares during the period. Finally, Canada Pension Plan Investment Board lifted its stake in shares of Endo International PLC by 93.4% during the 2nd quarter. Canada Pension Plan Investment Board now owns 565,240 shares of the company’s stock worth $6,314,000 after purchasing an additional 273,024 shares during the period. 90.50% of the stock is currently owned by hedge funds and other institutional investors.

About Endo International PLC

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

Earnings History and Estimates for Endo International PLC (NASDAQ:ENDP)

Receive News & Stock Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related stocks with our FREE daily email newsletter.